Microtubule Active Agents : Beyond the Taxane FrontierMORRIS, Patrick G; FORNIER, Monica N.Clinical cancer research (Print). 2008, Vol 14, Num 22, pp 7167-7172, issn 1078-0432, 6 p.Article

Flagellate erythema induced by docetaxelTALLON, B; LAMB, S.Clinical and experimental dermatology (Print). 2008, Vol 33, Num 3, pp 276-277, issn 0307-6938, 2 p.Article

Synergistic interaction between trifluorothymidine and docetaxel is sequence dependentBIJNSDORP, I. V; KRUYT, F. A; GOKOEL, S et al.Cancer science. 2008, Vol 99, Num 11, pp 2302-2308, issn 1347-9032, 7 p.Article

Effect of Food on the Pharmacokinetic Behavior of the Potent Oral Taxane BMS-275183BROKER, Linda E; VALDIVIESO, Manual; PILAT, Mary Jo et al.Clinical cancer research. 2008, Vol 14, Num 13, pp 4186-4191, issn 1078-0432, 6 p.Article

Unraveling the multispecificity and catalytic promiscuity of taxadiene monooxygenaseYADAV, Vikramaditya G.Journal of molecular catalysis. B, Enzymatic. 2014, Vol 110, pp 154-164, issn 1381-1177, 11 p.Article

Influence of Polymorphic OATP1 B-Type Carriers on the Disposition of DocetaxelDE GRAAN, Anne-Joy M; LANCASTER, Cynthia S; CORYDON, Thomas J et al.Clinical cancer research (Print). 2012, Vol 18, Num 16, pp 4433-4440, issn 1078-0432, 8 p.Article

Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane TherapyDE GRAAN, Anne-Joy M; LOOS, Walter J; FRIBERG, Lena E et al.Clinical cancer research (Print). 2012, Vol 18, Num 16, pp 4425-4432, issn 1078-0432, 8 p.Article

Taxane's Substituents at C3' Affect Its Regioselective Metabolism : Different in Vitro Metabolism of Cephalomannine and PaclitaxelZHANG, Jiang-Wei; GE, Guang-Bo; XIAO, Hong-Bin et al.Drug metabolism and disposition. 2008, Vol 36, Num 2, pp 418-426, issn 0090-9556, 9 p.Article

Functional Characterization of CYP2C8.13 and CYP2C8.14: Catalytic Activities toward PaclitaxelHANIOKA, Nobumitsu; MATSUMOTO, Kimiaki; SAITO, Yoshiro et al.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 107, Num 1, pp 565-569, issn 1742-7835, 5 p.Article

Influence of Drug Formulation on OATP1B-Mediated Transport of PaclitaxelNIEUWEBOER, Annemieke J. M; SHUIYING HU; CHUNSHAN GUI et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 11, pp 3137-3145, issn 0008-5472, 9 p.Article

Diagnosis: Docetaxel (Taxotere)-induced photosensitivityAGARWAL, Ankit; MEHTA, Amol; LOGESWARAN, Prashanti et al.Archives of otolaryngology, head & neck surgery. 2012, Vol 138, Num 9, pp 869-870, issn 0886-4470, 2 p.Article

Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant TumorsVRIGNAUD, Patricia; SEMIOND, Dorothée; LEJEUNE, Pascale et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 2973-2983, issn 1078-0432, 11 p.Article

Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor SystemNAGUIB, Mohamed; XU, Jijun J; DIAZ, Philippe et al.Anesthesia and analgesia. 2012, Vol 114, Num 5, pp 1104-1120, issn 0003-2999, 17 p.Article

Relationship between the Structures of Taxane Derivatives and Their Microtubule Polymerization ActivityHIDAKA, Masafumi; KOGA, Tomoe; KIYOTA, Hiromasa et al.Bioscience, biotechnology, and biochemistry. 2012, Vol 76, Num 2, pp 349-352, issn 0916-8451, 4 p.Article

Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantationKABAR, I; CICINNATI, V. R; BECKEBAUM, S et al.Endoscopy (Stuttgart). 2012, Vol 44, Num 12, pp 1158-1160, issn 0013-726X, 3 p.Article

The role of Tau protein in resistance to paclitaxelSMOTER, Marta; BODNAR, Lubomir; DUCHNOWSKA, Renata et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 3, pp 553-557, issn 0344-5704, 5 p.Article

A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor BearersKODUMUDI, Krithika N; WOAN, Karrune; GILVARY, Danielle L et al.Clinical cancer research (Print). 2010, Vol 16, Num 18, pp 4583-4594, issn 1078-0432, 12 p.Article

Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic ProfilingLIANGLI ZHAO; LEE, Brian Y; SUTHERLAND, Robert L et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7696-7703, issn 0008-5472, 8 p.Article

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid TumorsMITA, Alain C; DENIS, Louis J; SEMIOND, Dorothée et al.Clinical cancer research (Print). 2009, Vol 15, Num 2, pp 723-730, issn 1078-0432, 8 p.Article

Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity : Effects of Docetaxel on Immune EnhancementGARNETT, Charlie T; SCHLOM, Jeffrey; HODGE, James W et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3536-3544, issn 1078-0432, 9 p.Article

Cellular Mechanisms of Resistance to Anthracyclines and Taxanes in Cancer : Intrinsic and AcquiredCHIEN, A. Jo; MOASSER, Mark M.Seminars in oncology. 2008, Vol 35, Num 2, issn 0093-7754, S1-S14, SUP2Article

A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET PlatformDE GRAAN, Anne-Joy M; ELENS, Laure; VERWEIJ, Jaap et al.Clinical cancer research (Print). 2013, Vol 19, Num 18, pp 5210-5217, issn 1078-0432, 8 p.Article

Self-assembled micelles of monosialogangliosides as nanodelivery vehicles for taxanesLEONHARD, Victoria; ALASINO, Roxana V; BIANCO, Ismael D et al.Journal of controlled release. 2012, Vol 162, Num 3, pp 619-627, issn 0168-3659, 9 p.Article

Modulating Microtubule Stability Enhances the Cytotoxic Response of Cancer Cells to PaclitaxelASHOUR AHMED, Ahmed; XIAOYAN WANG; ZHEN LU et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5806-5817, issn 0008-5472, 12 p.Article

Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1LOPRINZI, Charles L; REEVES, Brandi N; NOVOTNY, Paul J et al.Journal of clinical oncology. 2011, Vol 29, Num 11, pp 1472-1478, issn 0732-183X, 7 p.Article